FURTHER EVIDENCE OF BENEFITS OF A (NONRANDOMIZED) BREAST-CANCER SCREENING-PROGRAM - THE DOM PROJECT

被引:18
作者
COLLETTE, HJA [1 ]
DEWAARD, F [1 ]
ROMBACH, JJ [1 ]
COLLETTE, C [1 ]
DAY, NE [1 ]
机构
[1] MRC, BIOSTAT UNIT, CAMBRIDGE, ENGLAND
关键词
D O I
10.1136/jech.46.4.382
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Study objective-The aim was to demonstrate the benefits of breast cancer screening on mortality. Design-The study was an evaluation of a breast cancer screening programme by means of different approaches: (1) a case-control study, breast cancer deaths being the cases; (2) comparing the numbers of breast cancer deaths in screened and unscreened women; (3) comparing breast cancer mortality before and after start of the programme; (4) comparing breast cancer mortality in different large cities; (5) comparing screening activity with mortality reduction. Setting-The setting was a breast cancer screening programme in the city of Utrecht, the DOM project, for women aged 50-64 years old at intake, birth cohort 1911-1925. The programme started in 1974, and there were five screening rounds up to 1984. Participation rate in the first round was 72% (14 697 women). Main results-(1) Screening was protective against dying from breast cancer, odds ratio 0.52, with a stronger effect in older women and no evidence of confounding; (2) risk ratio of dying from breast cancer for women in the response group was the same as the odds ratio, 0.52; (3) breast cancer death rate after the start of the project was nearly 20% lower than before the project started; after correcting for women who could not have benefited from screening the reduction was 33%; (4) a rise in breast cancer mortality in birth cohort 1911-1925 seen in other large cities without a screening programme due to aging of the cohort was not seen in the city of Utrecht; (5) mortality reduction followed the screening activity with a time lag of approximately 5 years. Conclusions-Early diagnosis of breast cancer by mammography reduces breast cancer mortality in women 50-64 years old at intake; different approaches to the evaluation of the project give different estimates of the screening effect, making clear that the effect depends on the intensity of the programme.
引用
收藏
页码:382 / 386
页数:5
相关论文
共 16 条
  • [1] MAMMOGRAPHIC SCREENING AND MORTALITY FROM BREAST-CANCER - THE MALMO MAMMOGRAPHIC SCREENING TRIAL
    ANDERSSON, I
    ASPERGREN, K
    JANZON, L
    LANDBERG, T
    LINDHOLM, K
    LINELL, F
    LJUNGBERG, O
    RANSTAM, J
    SIGFUSSON, B
    [J]. BRITISH MEDICAL JOURNAL, 1988, 297 (6654) : 943 - 948
  • [2] BOYD NF, 1981, JNCI-J NATL CANCER I, V67, P785
  • [3] CLARKE EA, 1979, LANCET, V2, P1
  • [4] COLLETTE HJA, 1984, LANCET, V1, P1224
  • [5] COLLETTE HJA, 1988, SCREENING BREAST CAN, P17
  • [6] CRAMER DW, 1974, CANCER, V34, P2018, DOI 10.1002/1097-0142(197412)34:6<2018::AID-CNCR2820340621>3.0.CO
  • [7] 2-B
  • [8] de Waard F, 1985, Ned Tijdschr Geneeskd, V129, P454
  • [9] THE DOM PROJECT FOR THE EARLY DETECTION OF BREAST-CANCER, UTRECHT, THE NETHERLANDS
    DEWAARD, F
    COLLETTE, HJA
    ROMBACH, JJ
    BAANDERSVANHALEWIJN, EA
    HONING, C
    [J]. JOURNAL OF CHRONIC DISEASES, 1984, 37 (01): : 1 - 44
  • [10] SCREENING MAMMOGRAPHY
    GULLBERG, B
    ANDERSSON, I
    JANZON, L
    RANSTAM, J
    [J]. LANCET, 1991, 337 (8735) : 244 - 244